Tert-Butyl 7-Oxo-6,7-Dihydrothieno[3,2-C]Pyridine-5(4H)-Carboxylate
95%
- Product Code: 242768
CAS:
478628-26-1
| Molecular Weight: | 253.31 g./mol | Molecular Formula: | C₁₂H₁₅NO₃S |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD23378386 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature, sealed, dry |
Product Description:
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective modification, making it valuable in creating potent bioactive molecules. Commonly employed in medicinal chemistry for constructing heterocyclic frameworks found in drug candidates. Also utilized in research settings to explore new therapeutic agents targeting inflammatory diseases and neurological disorders.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 0.100 | 10-20 days | €507.69 |
+
-
|
| 0.250 | 10-20 days | €858.88 |
+
-
|
Tert-Butyl 7-Oxo-6,7-Dihydrothieno[3,2-C]Pyridine-5(4H)-Carboxylate
Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of kinase inhibitors for cancer treatment. Its structure allows for selective modification, making it valuable in creating potent bioactive molecules. Commonly employed in medicinal chemistry for constructing heterocyclic frameworks found in drug candidates. Also utilized in research settings to explore new therapeutic agents targeting inflammatory diseases and neurological disorders.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
€0.00
€0.00
Total :